📱

Read on Your E-Reader

Thousands of readers get articles like this delivered straight to their e-reader. Works with Kindle, Boox, and any device that syncs with Google Drive or Dropbox.

Learn More

This is a preview. The full article is published at wsj.com.

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

By Colin KellaherJanuary 15, 2026WSJ.com: World News

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.

Preview: ~25 words

Continue reading at Wsj

Read Full Article

More from WSJ.com: World News

Subscribe to get new articles from this feed on your e-reader.

View feed

This preview is provided for discovery purposes. Read the full article at wsj.com. LibSpace is not affiliated with Wsj.